FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE — Supplemental Application (H2-Pharma, LLC)

View source ↗

Summary

FDA approved a supplemental application for the fixed-dose combination of bismuth subcitrate potassium, metronidazole, and tetracycline hydrochloride (H2-Pharma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Gastric Ulcer
• Helicobacter Pylori Infection
• Peptic Ulcer Disease

Drugs mentioned

• Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride (Bismuth Subcitrate Potassium; Metronidazole; Tetracycline Hydrochloride)

Snippet

SUPPL AP for BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE (BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE)